From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health

The complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the le...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharfstein, Joshua M., Conti, Rena M., Gee, Rebekah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341206/
https://www.ncbi.nlm.nih.gov/pubmed/35902083
http://dx.doi.org/10.1017/jme.2022.32
_version_ 1784760563773997056
author Sharfstein, Joshua M.
Conti, Rena M.
Gee, Rebekah E.
author_facet Sharfstein, Joshua M.
Conti, Rena M.
Gee, Rebekah E.
author_sort Sharfstein, Joshua M.
collection PubMed
description The complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the lessons of the national COVID vaccine campaign to HIV prevention. In doing so, it draws on other examples of public health approaches to the financing of medical technology, from vaccines for children to hepatitis C treatment.
format Online
Article
Text
id pubmed-9341206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-93412062022-08-12 From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health Sharfstein, Joshua M. Conti, Rena M. Gee, Rebekah E. J Law Med Ethics Commentary The complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the lessons of the national COVID vaccine campaign to HIV prevention. In doing so, it draws on other examples of public health approaches to the financing of medical technology, from vaccines for children to hepatitis C treatment. Cambridge University Press 2022 /pmc/articles/PMC9341206/ /pubmed/35902083 http://dx.doi.org/10.1017/jme.2022.32 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Sharfstein, Joshua M.
Conti, Rena M.
Gee, Rebekah E.
From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health
title From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health
title_full From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health
title_fullStr From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health
title_full_unstemmed From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health
title_short From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public’s Health
title_sort from covid vaccines to hiv prevention: pharmaceutical financing and distribution for the public’s health
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341206/
https://www.ncbi.nlm.nih.gov/pubmed/35902083
http://dx.doi.org/10.1017/jme.2022.32
work_keys_str_mv AT sharfsteinjoshuam fromcovidvaccinestohivpreventionpharmaceuticalfinancinganddistributionforthepublicshealth
AT contirenam fromcovidvaccinestohivpreventionpharmaceuticalfinancinganddistributionforthepublicshealth
AT geerebekahe fromcovidvaccinestohivpreventionpharmaceuticalfinancinganddistributionforthepublicshealth

Ejemplares similares